BRIDGET TAN: Open Payments
NPI 1295233625 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,173 in 82 payments from 16 companies in 2025. Trend: 2023 $732 · 2024 $819 · 2025 $1,173
Food & beverage: $1,173
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $396 |
| PFIZER INC. | 14 | $152 |
| Otsuka America Pharmaceutical, Inc. | 11 | $151 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $70 |
| Novo Nordisk Inc | 4 | $68 |
| Astellas Pharma US Inc | 3 | $56 |
| Abbott Laboratories | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
Products named: VRAYLAR, REXULTI, UBRELVY, XIFAXAN, BREZTRI, Veozah, Ozempic, ELIQUIS.
Industry payments across OH — which companies pay providers there.
